Tuesday, March 15, 2016

BRIEF-Orexigen says acquired all U.S. rights to Contrave

* Orexigen announces strategic acquisition of all U.S. rights to Contrave, the market leading branded anti-obesity prescription medicine

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)